Patent · US Active

Immunogenic composition

US8398983B2 · kind B2 · utility

11Cited by

17References

31Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Ralph Leon Biemans · Rixensart, BE
Dominique Boutriau · Rixensart, BE
Carine Capiau · Rixensart, BE
Philippe Denoel · Rixensart, BE
Pierre Duvivier · Rixensart, BE
Jan Poolman · Broek in Waterland, NL

Key dates

Filing date	Jun 23, 2006
Grant date	Mar 19, 2013
Priority date	—
Expiry date	Feb 26, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application discloses an immunogenic composition comprising a Hib saccharide conjugate, at least one additional bacterial, for example N. meningitidis, saccharide conjugate(s), and a further antigen selected from the group consisting of whole cell pertussis and hepatitis B surface antigen, wherein the saccharide dose of the Hib saccharide conjugate is less than 5 ug.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.